iDtheinvestordatabase
Home / Directory / F-Prime Capital
Activity not yet confirmed Verified 4 Nov 2026

F-Prime Capital

Fidelity-rooted venture firm investing in life sciences, healthtech and services, enterprise software, fintech, frontier tech and crypto. Early stage by preference but backs teams at any stage; offices in Cambridge MA, London and San Francisco.

Type
VC firm
Location
United States (Cambridge office)
Stages
Any stage
Backs
Biotech and pharma, Medtech and digital health, Crypto and web3
Sectors
Healthtech and life sciences, Biotech, Crypto, Fintech, SaaS and software, Deep tech
Fund size / AUM
$5.3bn+ under management
Portfolio mix
Biotech and pharma 34%; Medtech and digital health 29%; Crypto and web3 21%; B2B software 13%; Fintech 3% (n=20, 2011 to 2026)

Contacts on file

For F-Prime Capital, the paid file holds: 8 named decision-makers with roles; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

Beam TherapeuticsToastDenali TherapeuticsInnoventUltragenyx

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 22 lists

Deep tech investors in Massachusetts (20)Fintech investors in Massachusetts (26)Medtech investors in Massachusetts (37)Biotech investors in Massachusetts (37)SaaS investors in Massachusetts (55)Healthtech investors in Massachusetts (58)Crypto and web3 venture capital firms in the US (116)Crypto and web3 investors (143)Venture capital firms in Massachusetts (185)Biotech venture capital firms in the US (297)Deep tech venture capital firms in the US (322)Medtech venture capital firms in the US (350)Medtech investors (457)Biotech investors (484)Fintech venture capital firms in the US (525)Healthtech venture capital firms in the US (709)Deep tech investors (763)Fintech investors (846)SaaS venture capital firms in the US (1,049)Healthtech investors (1,207)SaaS investors (1,529)Venture capital firms in the US (2,975)